Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid CancerLivia Lamartina, Sophie Leboulleux|The Journal of Clinical Endocrinology & Metabolism|2016Cited by 45